MEK2 (MAP2K2) Mouse Monoclonal Antibody [Clone ID: LBI5B4] AMM13432V
Specifications
| 100ul / 30ul |
Product overview:
MAP2K2 (MEK2 ) mouse monoclonal antibody, clone LBI5B4
Field of research:
Acute myeloid leukemia, B cell receptor signaling pathway, Bladder cancer, Chronic myeloid leukemia, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pathways in cancer, Prion diseases, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, Thyroid cancer, Toll-like receptor signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway
Summary:
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq]
Alternative names:
CFC4; MAPKK2; MEK2; MKK2; PRKMK2
Species reactivity:
Human, Mouse, Rat, Dog
Host:
Mouse
Target:
MAP2K2
Isotype:
IgG1
Immunogen:
Full length human recombinant protein of human MAP2K2(NP_109587) produced in HEK293T cell.
Clone:
LBI5B4
Conjugation:
Unconjugated
Gene name:
mitogen-activated protein kinase kinase 2
Symbol:
MAP2K2
Pathway:
Acute myeloid leukemia, B cell receptor signaling pathway, Bladder cancer, Chronic myeloid leukemia, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pathways in cancer, Prion diseases, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, Thyroid cancer, Toll-like receptor signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway
Function:
Druggable Genome, Protein Kinase
Purification:
Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Concentration:
1 mg/ml
Form:
PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Applications & dilution:
WB 1:200~2000, IF 1:100
Storage buffer:
PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Storage:
Store at +4°C short term. For long-term storage, aliquot and store at -20°C or below. Stable for 12 months at -20°C. Avoid repeated freeze-thaw cycles.
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
